Cite
Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials
MLA
Andres Acosta, et al. “Early Investigational Therapeutics for Gastrointestinal Motility Disorders: From Animal Studies to Phase II Trials.” Expert Opinion on Investigational Drugs, vol. 24, May 2015, pp. 769–79. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....279df4809029d888a7dfd8b9ae5336bf&authtype=sso&custid=ns315887.
APA
Andres Acosta, Michael Camilleri, & Nelson Valentin. (2015). Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials. Expert Opinion on Investigational Drugs, 24, 769–779.
Chicago
Andres Acosta, Michael Camilleri, and Nelson Valentin. 2015. “Early Investigational Therapeutics for Gastrointestinal Motility Disorders: From Animal Studies to Phase II Trials.” Expert Opinion on Investigational Drugs 24 (May): 769–79. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....279df4809029d888a7dfd8b9ae5336bf&authtype=sso&custid=ns315887.